Urovant Sciences

Urovant Sciences, a biopharmaceutical company based in Irvine, California, employs 99 individuals and generates approximately $100 million in annual revenue. The company is now known as Sumitomo Pharma America (SMPA). SMPA focuses on developing innovative therapies for urologic conditions. They strive to address the often-overlooked and underserved needs of patients suffering from these conditions. Through research and development, SMPA aims to provide solutions that improve the lives of individuals impacted by urologic diseases. SMPA is committed to advancing urologic patient care through bold innovation and a collaborative approach. They emphasize diversity of thought, openness to new ideas, adaptability, integrity, and compassion in their pursuit of therapeutic breakthroughs. For more information on SMPA, visit their website at urovant.com.